In the interests of full disclosure, I am out as of the 4C
The long term thesis is still likely in-tact, however the price dropped sufficiently (prior to today) for me to justify moving out, accepting a tax event and looking elsewhere for the meantime.
The delay to Daly rollout in major retailers was a factor, the current broader market conditions, and my predicted timelines for further company advancement. PFT still at the top of my watchlist.
- Forums
- ASX - By Stock
- PFT
- Ann: Investor Presentation - Webinar 28 January 2021
Ann: Investor Presentation - Webinar 28 January 2021, page-31
Featured News
Add PFT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.843M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PFT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online